Gefitinib Accord

Gefitinib Accord is an oral medication used to treat certain types of cancer. This pharmaceutical is manufactured by Accord Healthcare Polska Sp. Z O.O. and is intended for oral use.

Gefitinib Accord is primarily used in the treatment of specific types of cancer. It works by targeting certain proteins that help cancer cells grow and divide. This medication is often prescribed for patients with non-small cell lung cancer that has specific genetic features.

Common effects of Gefitinib Accord may include skin rash, diarrhea, and dry skin. Some users might also experience nausea, vomiting, or appetite loss. It's important to discuss any persistent or severe side effects with a healthcare provider.

Gefitinib Accord should be handled with care and stored as directed. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may not be suitable for everyone, especially those with certain medical conditions or allergies.

Gefitinib Accord can interact with other medications, including certain antibiotics, antifungals, and seizure medications. It is crucial to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, grapefruit and grapefruit juice should be avoided as they can affect how this medication works.